Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Andrews

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
International Journal of Cancer|September 30, 1991
TRA-1-60: a new serum marker in patients with germ-cell tumorsJ Marrink, P W Andrews, P J van Brummen, et al.
Annals of Surgical Oncology|June 1, 1997
Importance of a new tumor marker TRA-1-60 in the follow-up of patients with clinical stage I nonseminomatous testicular germ cell tumorsM E Gels, J Marrink, P Visser, et al.
International Journal of Andrology|February 10, 2006
Dysfunction of the mitotic:meiotic switch as a potential cause of neoplastic conversion of primordial germ cellsD J B Adamah, P J Gokhale, D J Eastwood, et al.
Human Reproduction (Oxford, England)|February 16, 2006
Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation eventsR Harun, L Ruban, M Matin, et al.
International Journal of Andrology|June 10, 2011
Mapping the stem cell state: eight novel human embryonic stem and embryonal carcinoma cell antibodiesA Wright, N Andrews, K Bardsley, et al.
International Journal of Cancer|June 11, 1996
Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumoursP W Andrews, J Casper, I Damjanov, et al.
Nature Nanotechnology|November 8, 2011
Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thicknessA Sood, S Salih, D Roh, et al.
Regenerative Medicine|February 13, 2015
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)P W Andrews, D Baker, N Benvinisty, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
International Journal of Cancer|September 30, 1991
TRA-1-60: a new serum marker in patients with germ-cell tumorsJ Marrink, P W Andrews, P J van Brummen, et al.
Annals of Surgical Oncology|June 1, 1997
Importance of a new tumor marker TRA-1-60 in the follow-up of patients with clinical stage I nonseminomatous testicular germ cell tumorsM E Gels, J Marrink, P Visser, et al.
International Journal of Andrology|February 10, 2006
Dysfunction of the mitotic:meiotic switch as a potential cause of neoplastic conversion of primordial germ cellsD J B Adamah, P J Gokhale, D J Eastwood, et al.
Human Reproduction (Oxford, England)|February 16, 2006
Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation eventsR Harun, L Ruban, M Matin, et al.
International Journal of Andrology|June 10, 2011
Mapping the stem cell state: eight novel human embryonic stem and embryonal carcinoma cell antibodiesA Wright, N Andrews, K Bardsley, et al.
International Journal of Cancer|June 11, 1996
Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumoursP W Andrews, J Casper, I Damjanov, et al.
Nature Nanotechnology|November 8, 2011
Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thicknessA Sood, S Salih, D Roh, et al.
Regenerative Medicine|February 13, 2015
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)P W Andrews, D Baker, N Benvinisty, et al.
Pageof 9